This work presents an antibody-drug conjugate platform for cancer therapy, indicating potential advancements in targeted treatment strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Câmara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: